Mesothelioma Blog, Important Mesothelioma Research and information
SearchTags: alfacell05th May 2006 : Alfacell Provides Update on ONCONASE Phase IIIb Confirmatory Registration Trial; Releases First Interim Analysis DataAlfacell Corporation (Nasdaq: ACEL - News) today announced that the 210 events (deaths) has been reached in its confirmatory Phase IIIb registration trial evaluating ONCONASE® (ranpirnase), the Company's lead investigational drug candidate, as a treatmen… more » Categories: Mesothelioma News |
|
||||
